Sectoral Asset Management Inc Bei Gene, Ltd. Transaction History

Sectoral Asset Management Inc

$88.6 Million
Q2 2025

A detailed history of Sectoral Asset Management Inc transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 7,716 shares of BGNE stock, worth $1.75 Million. This represents 1.97% of its overall portfolio holdings.

Number of Shares

7,716

Previous 2,927 163.61%

Holding current value

$1.75 Million

Previous $663,000 163.8%

% of portfolio

1.97%

Previous 0.75%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	N/A	4,789 Added 163.61%	7,716 $1.75 Million
Q1 2025 May 15, 2025	BUY	$175.1 - $226.71 $160,566 - $207,893	917 Added 45.62%	2,927 $663,000
Q4 2024 Feb 14, 2025	SELL	$174.72 - $246.04 $109,549 - $154,267	-627 Reduced 23.78%	2,010 $371,000
Q3 2024 Nov 14, 2024	BUY	$143.93 - $224.51 $27,346 - $42,656	190 Added 7.76%	2,637 $592,000
Q2 2024 Aug 13, 2024	SELL	$129.52 - $174.32 $161,252 - $217,028	-1,245 Reduced 33.72%	2,447 $349,000
Q1 2024 May 14, 2024	SELL	$141.8 - $181.47 $8,508 - $10,888	-60 Reduced 1.6%	3,692 $577,000
Q4 2023 Feb 14, 2024	BUY	$158.67 - $201.58 $66,641 - $84,663	420 Added 12.61%	3,752 $676,000
Q3 2023 Nov 14, 2023	SELL	$179.87 - $225.13 $443,919 - $555,620	-2,468 Reduced 42.55%	3,332 $599,000
Q2 2023 Aug 11, 2023	BUY	$178.3 - $266.78 $51,707 - $77,366	290 Added 5.26%	5,800 $1.03 Million
Q1 2023 May 12, 2023	SELL	$215.53 - $274.5 $101,299 - $129,015	-470 Reduced 7.86%	5,510 $1.19 Million
Q4 2022 Feb 10, 2023	BUY	$125.51 - $229.3 $25,102 - $45,860	200 Added 3.46%	5,980 $1.32 Million
Q3 2022 Nov 10, 2022	BUY	$131.8 - $202.24 $92,260 - $141,568	700 Added 13.78%	5,780 $779,000
Q2 2022 Aug 15, 2022	BUY	$121.11 - $216.05 $60,555 - $108,025	500 Added 10.92%	5,080 $822,000
Q1 2022 May 10, 2022	SELL	$146.52 - $269.56 $29,304 - $53,912	-200 Reduced 4.18%	4,580 $864,000
Q4 2021 Feb 11, 2022	SELL	$248.56 - $389.34 $303,243 - $474,994	-1,220 Reduced 20.33%	4,780 $1.3 Million
Q2 2021 Aug 16, 2021	BUY	$292.75 - $367.01 $58,550 - $73,402	200 Added 3.45%	6,000 $2.06 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $1.51 Million - $2.22 Million	5,800 New	5,800 $2.02 Million
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $1.35 Million - $1.66 Million	-11,227 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$113.99 - $146.86 $34,197 - $44,058	300 Added 2.75%	11,227 $1.39 Million
Q1 2019 May 14, 2019	SELL	$122.82 - $151.83 $491,280 - $607,320	-4,000 Reduced 26.8%	10,927 $1.44 Million
Q4 2018 Feb 12, 2019	BUY	$107.01 - $175.15 $535,050 - $875,750	5,000 Added 50.37%	14,927 $2.09 Million
Q3 2018 Nov 14, 2018	BUY	$152.62 - $189.66 $1.52 Million - $1.88 Million	9,927 New	9,927 $1.71 Million

Others Institutions Holding BGNE

# of Institutions

286

Shares Held

32.2M

Call Options Held

113K

Put Options Held

106K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Bei Gene, Ltd. Transaction History